Feed type
Twitter
Post created date
2025-04-09
Post ID
1909984708403863705
A hybrid ablation procedure is currently being studied in the HEAL-IST Trial to treat patients with symptomatic IST who are intolerant or refractory to medications. Learn more about who might qualify: <a href="https://t.co/GctEkS7k6a" target="_blank">https://t.co/GctEkS7k6a</a>
<a href="https://twitter.com/hashtag/ClinicalTrial?src=hashtag_click" target="_blank">#ClinicalTrial</a> <a href="https://twitter.com/hashtag/CardioTwitter?src=hashtag_click" target="_blank">#CardioTwitter</a>
Post image URL
https://pbs.twimg.com/media/GoGg-EOWwAAh73_.jpg
Post URL
https://t.co/JS0qoHgj2K
Post creted timestamp
